Pharmacological and clinical profiles of a human GLP-1 analogue, liraglutide (Victoza(®))

Saved in:
Bibliographic Details
Published inNihon yakurigaku zasshi Vol. 136; no. 4; p. 233
Main Authors Sugii, Hiroshi, Matsumura, Yoriko, Inoue, Akihiro, Horigome, Hiroaki, Matsuzaki, Katsuhiro, Shimizu, Akane
Format Journal Article
LanguageJapanese
Published Japan 2010
Subjects
Animals
Blood Glucose - drug effects
Carcinogens
Cells, Cultured
Diabetes Mellitus, Type 2 - drug therapy
Glucagon-Like Peptide 1 - analogs & derivatives
Glucagon-Like Peptide 1 - pharmacology
Glucagon-Like Peptide 1 - therapeutic use
Humans
Hypoglycemic Agents - pharmacology
Hypoglycemic Agents - therapeutic use
Insulin-Secreting Cells - drug effects
Liraglutide
Mice
Rats
Online AccessGet more information

Cover

More Information
ISSN:0015-5691
DOI:10.1254/fpj.136.233